Trial NCT02951156

View at ClinicalTrials.gov 
Org. Study IDs: B9991011
Secondary IDs: 2016-002904-15

Last trial update was posted on 2020-12-17

MeSH Interventions

Avelumab Azacitidine Bendamustine Hydrochloride Gemcitabine Oxaliplatin Rituximab

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Other Conditions

Diffuse Large B-Cell Lymphoma

Stopping Reasons

Study was terminated due to closure of study arms following futility analysis and difficulty in enrolling participants due to evolving treatment landscape

Limitations And Caveats

Data for Phase 3 outcome measures were not collected as study was terminated early and phase 3 was not conducted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID